Lewes, DE -- (SBWIRE) -- 11/13/2013 -- LeadingStockAlerts is a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community. Out Today’s Focus is on: Array Biopharma Inc (NASDAQ:ARRY), Apollo Investment Corp. (NASDAQ:AINV), BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX), Novavax, Inc. (NASDAQ:NVAX)
Array Biopharma Inc (NASDAQ:ARRY) opened its shares at the price of $5.48 for the day. Its closing price was $5.70 after gaining +3.45% for the day. The company traded with the total volume of 1.32 million shares, while its average trading volume remained 2.01 million shares. The beta of ARRY stands at1.67. Array BioPharma Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule drugs to treat patients afflicted with cancer and inflammatory diseases primarily in North America.
For How Long ARRY will Fight for Profitability? Read This Trend Analysis report
Apollo Investment Corp. (NASDAQ:AINV) percentage change surged +0.12% to close at $8.63 with the total traded volume of 1.30 million shares, and average volume of 1.62 million. The 52 week range of the stock remained $7.21 - $9.08, while its day lowest price was $8.57 and it hit its day highest price at $8.68. Apollo Investment Corporation is business development company and operates as a closed-end management investment company. The company invests in middle market companies.
For How Long AINV’s Gloss will Attract Investors? Find out via this report
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) started its trading session with the price of $5.99 and closed at $5.63 by scoring -2.09%. BCRX’s stocks traded with total volume of 1.29 million shares, while the average trading volume remained 1.01 million shares. The beta of BCRX stands at 2.97. Day range of the stock was $5.59 -$6.32. BioCryst Pharmaceuticals, Inc., a biotechnology company, designs, optimizes, and develops novel drugs that block key enzymes involved in the pathogenesis of diseases. The company integrates the disciplines of biology.
Has BCRX Found The Bottom And Ready To Gain Momentum? Find Out Here
Novavax, Inc. (NASDAQ:NVAX) ended its day with the loss of -4.04% and closed at the price of $2.85 after opening at $2.95. Stock traded during its last trading session with the total volume of 1.29 million shares, as compared to its average volume of 2.65 million shares. Novavax, Inc., a clinical-stage biopharmaceutical company, focuses on developing recombinant protein nanoparticle vaccines to address a range of infectious diseases.
Why Should Investors Buy NVAX After the Recent Fall? Just Go Here and Find Out
LeadingStockAlerts is a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community.
Our site has been the clear choice for today’s investors and day-traders. As one of the internet’s premiere financial destinations, we offer the investment community some of the market’s leading emerging opportunities. Using a balanced combination of industry experience and high-tech offerings, this site keeps you ahead of the curve and ahead of the bell.
DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT OR WEBSITE. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice.
The information contained in our report should be viewed as commercial advertisement and is not intended to be investment advice. The report is not provided to any particular individual with a view toward their individual circumstances. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.
Read Full Disclaimer at: http://leadingstockalerts.com/disclaimer/